Please assess the completion status of the following clinical trial:

Trial Title: Bronchoscopic Laser Ablation of Peripheral Lung Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* Performance status 0-2 (Eastern Cooperative Oncology Group classification)~* Subject is considered a candidate for bronchoscopy~* Subject is considered a candidate for surgery (other lobar or sub-lobar resection) based on radiographic staging and functional evaluation~* Lung lesion that is either biopsy-proven cancer or is suspicious for cancer~* Both non-small cell lung cancer (including carcinoid tumors) and metastatic disease~* The lesions should be: =\< 3 cm, located in the outer 2/3 of the lung, and leave \>= 1 cm of tumor-free lung parenchyma between target tumor and pleura or fissure~Exclusion Criteria:~* Tumors greater than 3 cm, located in the inner 1/3 of the lung, invading a major vessel, or located \< 1 cm from the pleural or fissure~* Tumors qualified as non-resectable~* Tumors that cannot be reached bronchoscopically~* Patients declared non-surgical candidates~* Patients who are not candidates for bronchoscopy~* Patients with lung cancer who are found to have N2-3 disease~* Patient with lung metastases who are found to have any malignant mediastinal lymph node~* Patients in which the target lesion is confirmed as benign or small cell lung cancer~* Patients without a prior diagnosis of the target lesion whose diagnosis cannot be made during bronchoscopy~* Patients who have received chemotherapy within 60 days prior to bronchoscopic laser ablation~* Patients who were previously treated for the target lesion~* Pregnant patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnostic (bronchoscopic laser ablation, CBCT) (Type: EXPERIMENTAL): Patients undergo bronchoscopic laser ablation following standard bronchoscopy and endobronchial ultrasound. Patients also undergo CBCT before and after laser ablation. 48-72 hours after the procedure, patients undergo standard surgical resection of the lung tumor.

Based on this trial design, predict the completion outcome and termination type (if applicable).